NCT02663674: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02663674 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (FLEET-Valley Fever) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 29, 2015 |
| Completion date | June 21, 2018 |
| Required reporting date | June 21, 2019, midnight |
| Actual reporting date | June 13, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |